Response of pups with maternal derived antibody to modified-live canine parvovirus vaccine.
The AA reports the results of vaccination against canine parvovirus (CPV) of pups with maternal antibody, utilizing a modified-live virus (MLV) CPV vaccine having a titer of 10(7) TCID50/dose. This vaccine was shown to be effective also when HI antibody titers of pups were < or = 1:80.
Buonavoglia
C
C
Istituto di Malattie infettive e parassitarie degli animali domestici, Facoltà di Medicina Veterinaria, Università degli Studi di Bari, Italy.
Tollis
M
M
Buonavoglia
D
D
Puccini
A
A
D000818:Animals; D000831:Animals, Newborn; D000914:Antibodies, Viral / Q000096:biosynthesis / Q000276:immunology; D004283:Dog Diseases / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D004285:Dogs; D007112:Immunity, Maternally-Acquired; D010321:Parvoviridae / Q000276:immunology*; D010322:Parvoviridae Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D014611:Vaccination / Q000662:veterinary; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000276:immunology
D000914:Antibodies, Viral; D014765:Viral Vaccines